Phase III AXIS trial for second-line metastatic renal cell carcinoma (mRCC): Effect of prior first-line treatment duration and axitinib dose titration on axitinib efficacy Meeting Abstract
| Authors: | Rini, B. I.; Escudier, B. J.; Michaelson, M. D.; Negrier, S.; Gore, M. E.; Oudard, S.; Clark, J.; Tarazi, J. C.; Rosbrook, B.; Kim, S.; Motzer, R. J. |
| Abstract Title: | Phase III AXIS trial for second-line metastatic renal cell carcinoma (mRCC): Effect of prior first-line treatment duration and axitinib dose titration on axitinib efficacy |
| Meeting Title: | 2012 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2012 Feb 2-4 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-02-10 |
| Language: | English |
| ACCESSION: | WOS:000208892400353 |
| DOI: | 10.1200/jco.2012.30.5_suppl.354 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 354 -- Source: Wos |
